Retinal Disease and Macular Disorders
King’s College London is involved in clinical research focused on exudative age-related macular degeneration, with particular attention to complications affecting the central retina and visual function.
- Wet age-related macular degeneration
- Submacular haemorrhage
- Macular pathology
The sponsor’s activity in this area reflects interest in conditions that threaten central vision and require specialised ophthalmic care.
Vitreoretinal Surgery
Its clinical portfolio includes research in vitrectomy and other vitreoretinal interventions used in the management of haemorrhagic complications associated with retinal disease.
- Vitrectomy
- Subretinal intervention
- Ophthalmic surgical treatment
This area highlights involvement in procedural approaches for complex posterior segment eye disease.
Anti-VEGF and Retinal Pharmacotherapy
Research activity also extends to anti-VEGF therapy, a key treatment domain in retinal vascular disease and neovascular complications of macular degeneration.
- Intravitreal anti-VEGF treatment
- Neovascular retinal disease
- Intravitreal therapy
The sponsor is engaged in clinical questions surrounding pharmacologic control of abnormal retinal blood vessel growth and related visual loss.
Posterior Segment Eye Care
King’s College London supports research addressing disorders of the posterior segment of the eye, where retinal damage and blood accumulation can lead to severe impairment.
- Subretinal TPA
- Intravitreal gas
- Vision-threatening retinal complications
These interests place emphasis on specialised treatment strategies for advanced ophthalmic disease.
